Prenatal Diagnosis of Homozygous Beta-Thalassemia by Fetal Hb Typing Analysis Using Automated HPLC

Authors

  • Torpong Sanguansermsri Department of Pediatrics, Faculty of Medicine, Chiang Mai University
  • Pattra Thanaratanakorn Department of Pediatrics, Faculty of Medicine, Chiang Mai University
  • HF Steger Department of Pediatrics, Faculty of Medicine, Chiang Mai University
  • Surasit Chomchuen Department of Pediatrics, Faculty of Medicine, Chiang Mai University
  • Theera Tongsong Department of Obstetrics-Gynecology, Faculty of Medicine, Chiang Mai University
  • Paruehut Chanprapas Department of Obstetrics-Gynecology, Faculty of Medicine, Chiang Mai University
  • Pannee Sirivantanapa Department of Obstetrics-Gynecology, Faculty of Medicine, Chiang Mai University
  • Supattra Sirichotiyakul Department of Obstetrics-Gynecology, Faculty of Medicine, Chiang Mai University

Keywords:

PND, Homozygous B-thalassemia, Fetal Hb typing, HPLC

Abstract

Background: Prenatal diagnosis is one of the method used for prevention and control of homozygous B-thalassemia. The method usually used is DNA analysis from chorionic vili and amniocytes, which are quite complicated and expensive. However, in Thailand the causes of this disease are mostly due to to -thalassemia genes, which cannot produce Hb A. Therefore, the measurement of Hb A percentage by automated HPLC could be an other helpful prenatal diagnostic method. Materials and methods: Forty pregnant
women, at a gestational age of between 18:22 weels were chosen. They were at risk of delivening a child with homozygous B-thalassemia. Cordocentesis was performed and fetal blood analyzed for Hb typing by automated HPLC. The P-globin gene mutation was demonstrated by direct B-globin gene sequencing. Results: There were 9 fetuses which had Hb F only. The DNA sequencing analysis of them showed 2 fetuses were homozygote of 4 bp deletion at codon 41/42 (-CTTT), 4 were combound heterozygoteof non-
sense mutation at codon 17 (A-T) and 4 bp deletion at codon 41/42 (-CTTT), 2 were homozygote of splice site mutation at IVSinti(G-T) and one fetus was compound heterozygote of nonsense mutation at codon 35(C-A) and 4 bo deletion at codon 41/42 (-CTTT). Thirty one fetuses showed Hb A in the HPLCchromatograms with the proportion from 05 to 7.4%. One fetus with Hb A of 05% was a case of compoundheterozygous promoter mutation at -28 (A-G) and 4bp deletion of codon 41/42 (-CTT). Twenty fetuses were B-thalassemia trait where 12 were 4 bp deletion at codon 41/42 (-CTT), 3 were IVSinti(G-T), 2 were nonsense mutation of codon 35 (C-A), 2 were promoter mutation at position -28 (A-G) and 1 was nonsensemutation at codon 17 (A-T). The proportion of Hb A of this group was 08-2.8% (1.8220.49). The other 10 fetuses showed Hb A of 2.9 - 7.4% (4.921.5) that had normal DNA sequencing. Conclusion: Prenatal diagnosis of homozygous B-thalassemia by Hb typing analysis using automated HPLC showed an absence of Hb A, which was the characteristic finding. The results were confimed by genotypes from DNA sequencing. It was suggested that the analysis of fetal hemoglobin is simple inexpensive and accurate for prenatal diagnosis. Therefore this method would be the most appropriate for the prevention and control of homozygous B-thalassemia throughout Thailand.

Downloads

Download data is not yet available.

References

ประเวศ วะสี (ร่าง) แผนงานธาลัสซีเมียแห่งชาติ มูลนิธโลหิตจางธาลัสซีเมียแห่งประเทศไทย พฤษภาคม 2539

Modell B. Total management of thalassemia major. Arch Dis Child 1997;52:487-500.

Porter JB. Excerpta Haematologica. Current strategies and perspectives in thalassemia treatment. Novartis Pharma Verlag. 90327 Nurnberg, Germany, 1999.

Winichagoon P, Fucharoen S, Siritanaratkuln, et al. Prenatal diagnosis for bata-thalassemia syndromes using HPR-labeled oligonucleotides probes at Siriraj Hospital. Southeast Asian J Trop Med Public Health 1995;16(suppl 1):282-6.

Winichagoon P, Saechan V, Sripanich R, et al. Prenatal diagnosis of beta-thalassemia by reverse dot blot hybridization. Prenat Diagn 1999:428-35-35.

Muralitharan S, Srivastava A, Shaji RV, et al. Prenatal diagnosis of beta-thalassemia mutations using the reverse dot blot technique. Nat Med J India 1996;9:70-1.

Chiou SS, Lin TC, Chang TT, et al. Prenatal and molecular diagnosis of beta-thalassemia major in Taiwan by naturally amplified created restriction sites. Int J Hematol 1993;59:1-8.

Laosombat V, Nopparat C, et al. Molecular basis of beta thalassemia in Thailand. Sigapore Paediatr J 1995;37:148-52.

Laig M, Sanguansermsri T, et al. The spectrum of beta-thalassemia mutations in northern and northeastern Thailand. Hum Gen 1988;84;47-50.

Sanguansermsri T, Chayutimulkul L. Globin synthesis in beta-thalassemic patients. J Med Ass Thai 1978;61:50-1.

Sanguansermsri T, Phumyu N, Chomchuen S, et al. Screening for Ot-thalassemia-1 heterozygotes in expecting couples by the combination of a simple erythrocyte osmotic fragility test and a PCR based method. Community Genetics 19999:26-9.

Sanguansermsri T, Tanpaiboon P, Wongmaeta S, et al. A2 test: A simple method for the screening of severe B-thalassemia trait. ThaiJ Hematol Transf Med 1999 (in press).

VARIANTTM Beta-Thalassemia Short Progam Instruction Manual. Bio-Rad Diagnostics California, USA, 1994.

Kitsirisakul B, Steger HF, Sanguansemsermsri T. Frequency of Ol-thalassemia-1 of the southeast Asian-type among pregnant women in northern Thailand determined by PCR technique. Southeast Asian J Trop Med Public Health. 1996;35:362-3.

ABI PRISM" DNA sequencing. Chemistry guides Perkin-Elmer, Foster City CA., USA. 19951-3

Gordkshakar AC, Lulla CP, Nadkarni AH, et al. Prenatal diagnosis of beta-thalassemia among Indians using denaturing gradient gel electrophoresis. Hemoglobin 1997;21:421-35.

Chang J G, Lu JM, Huang JE, et al. Rapid diagnosis of beta-thalassemia by mutagenically separated polymerase chain reaction (MS-PCR) and its application to prenatal diagnosis. Br J Haematol 1995,91.602-7.

XU XM, Ma WF, Song LL, et al. Direct genotyping and prenatal diagnosis of beta-thalassemia in Chinese by plymerase chain reaction mediated restriction fragment length polymorphism method. Clin Biochem 1993;26:497-503.

Trent RJ, Le H, Yu B. Prenatal diagnosis for thalassemia in a multicultural society. Prenat Diagn 1998;18:591-8.

Saxena R, Jain PK, Thomas E, et al. Prenatal diagnosis of beta-thalassemia: experience in a developing country. Prenat Diagn 1998;18:1-7.

Sanguansermsri T, Steger HF, Kongtaveelert P, et al. Prenatal diagnosis of homozygous &-thalassemia-1 by fetal hemoglobin typing with high performance liquid chromatography. Thai J Hematol Transf Med 1999 (in press).

Rao VB, Natrajan PG, Lulla CP, et al Rapid midtrimester prenatal diagnosis of beta-thalassemia and other haemoglobinopathies using a non-radioactive anion exchange HPLC techinique an Indian experience. Prenat Diagn 1997;17:725-31.

Maiavacca R, Tedeschi S, Mosca A, et al. Nonradioactive quantification of low concentrations of hemoglobin A by HPLC for midtimester prenatal diagnosis of beta-thalassemia. Clin Chem 1992;38:1906-8.

Berdoukas V, Argnle J, Cox W, et al. Prenatal diagnosis for hemoglobinopathies - 10 years experience using fetal blood sampling. Pathology

;25:48-51.

Downloads

Published

2018-12-30

Issue

Section

นิพนธ์ต้นฉบับ (Original article)